Documents
A list of downloadable documents created during development.
Melanoma (resected stage IV, high risk stage III) - ipilimumab (adjuvant): draft scope for consultation (pre-referral) - January 2014
-
Melanoma (resected stage IV, high risk stage III) - ipilimumab (adjuvant): draft scope for consultation (pre-referral) - January 2014
Melanoma (resected stage IV, high risk stage III) - ipilimumab (adjuvant): provisional matrix (pre-referral) - January 2014
-
Melanoma (resected stage IV, high risk stage III) - ipilimumab (adjuvant): provisional matrix (pre-referral) - January 2014